Autopsy report · NCT03053297
Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer)
Cause of deathRegulatory or ethics
“Cancelled due to changes in the scientific landscape. Decision was made after thorough evaluation of of pros\&cons, ethical as well as regulatory consideration”
Life of this trial
- Ran for about 8 months before it stopped.
- 89 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- AstraZeneca
- Sponsor type
- Industry
- Conditions
- Carcinoma, Non-Small-Cell Lung
- Interventions
- Patient Reported Outcomes
- Participants
- 89
- Sites
- 110
- Countries
- Canada, China, France, Spain, Taiwan, United Kingdom
Trials that died the same way
- A Study Of PF-06664178 In Patients With Advanced Solid Tumors
“The study was prematurely discontinued due to a business-related decision on 09-FEB-2016. The decision to terminate the trial was based on the overall results.” - Observational Study to Assess Migraine Prediction Tool
“The Sponsor decided to cancel the study due to commercial considerations” - Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 in Adults With NASH
“This study has been cancelled due to business reasons” - Effectiveness and Tolerance of Fentanyl Citrate in Painful Pain Induced During Diagnostic or Therapeutic Examinations in Cancer Patients
“Study was cancelled by Sponsor.” - Twelve Month Clinical Evaluation of KeraSoft IC Soft Contact Lenses
“Study was terminated due to a business decision to cancel the entire project.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.